Michael J. Reardon, MD

Allison Family Distinguished Chair of Cardiovascular Research, Department of Cardiovascular Surgery
Professor of Cardiovascular Surgery, Academic Institute
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Dr. Michael J. Reardon is a native Houstonian who attended Baylor College of Medicine where he graduated with honors and as a member of AOA. He did his general surgery residency under Dr. Michael DeBakey and cardiothoracic residency under Dr. Denton Cooley. He joined the staff of the Houston Methodist Hospital in 1985 and ran a private practice until 1993. He then joined the full time faculty of BCM rising to Professor of Surgery with tenure, Chief of Cardiothoracic Surgery and Director of the thoracic residency program. He subsequently joined the academic group at the HMH as Professor of Cardiothoracic Surgery and Chief of Cardiac Surgery.

His interests have centered on aortic surgery, cardiac valve surgery and cardiac tumors. His recent research and clinical interests have focused on minimally invasive, catheter-based approaches to these areas. He serves on the national steering committee for the CoreValve, SurTAVI and reprise III TAVR trials and as national surgical PI on the SurTAVI trial, reprise III trial and the Gore type A dissection trial. Dr. Reardon also serves as the international surgical PI for the Reprise III trial.

He holds the position of Clinical Professor of Cardiothoracic Surgery at MD Anderson Cancer Center and created the multi-institution, multidisciplinary cardiac tumor team with HMH and MDA. He has operated on more primary cardiac sarcomas than any other surgeon globally and written extensively on this topic. Dr. Reardon's group recently published the largest series of surgically treated primary cardiac sarcomas in the world. Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience PMID 26476808

He has served as elected president of the medical staff for the HMH and received numerous awards including the Overstreet Award and Noon Award. He currently holds the Allison Family Distinguished Chair of Cardiovascular Research and divides his time between building innovative clinical, research and educational programs.

Description of Research

He has been the principal and co-investigator on several industry and government-sponsored clinical trials and research initiatives, and he is currently on the national steering and screening committees for the Medtronic CoreValve US Pivotal Trial and the international steering committee for the SurTAVI Trial, for which he is also a national surgical principal investigator. His research interests include cardiac tumor treatment, catheter based approaches to structural heart disease, catheter based and open aortic disease treatment Having published more than 300 articles and abstracts, Dr. Reardon conducts peer reviews for publications such as the Annals of Thoracic Surgery and Circulation and is the associate editor of surgery for the Methodist DeBakey Cardiovascular Journal.

Areas Of Expertise

Cardiac tumor treatment Catheter based approaches to structural heart disease Catheter based and open aortic disease treatments Cardiac valve disease Aortic surgery Cardiac tumor surgery Complex cardiac surgery
Education & Training

MD, Baylor College of Medicine
Residency, Baylor College of Medicine
Certificate, Healthcare Management, Rice University
Fellow, Harvard University Alley-Sheridan School of Government
Residency, Texas Heart Institute
Active Clinical Trials

PERIGON Pivotal Trial



Transcatheter mitral valve replacement: an update
Aoun, J, Reardon, MJ & Goel, SS 2021, , Current Opinion in Cardiology, vol. 36, no. 4, pp. 384-389. https://doi.org/10.1097/HCO.0000000000000884

Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research
VARC-3 WRITING COMMITTEE: 2021, , Journal of the American College of Cardiology, vol. 77, no. 21, pp. 2717-2746. https://doi.org/10.1016/j.jacc.2021.02.038

Valve Academic Research Consortium 3: Updated endpoint definitions for aortic valve clinical research
Généreux, P, Piazza, N, Alu, MC, Nazif, T, Hahn, RT, Pibarot, P, Bax, JJ, Leipsic, JA, Blanke, P, Blackstone, EH, Finn, MT, Kapadia, S, Linke, A, Mack, MJ, Makkar, R, Mehran, R, Popma, JJ, Reardon, M, Rodes-Cabau, J, Van Mieghem, NM, Webb, JG, Cohen, DJ & Leon, MB 2021, , European heart journal, vol. 42, no. 19, pp. 1825-1857. https://doi.org/10.1093/eurheartj/ehaa799

Reply: On Evaluating Out-of-Hospital 30-Day Mortality After TAVR
Anwaruddin, S, Desai, N, Vemulapalli, S & Reardon, MJ 2021, , JACC: Cardiovascular Interventions, vol. 14, no. 9, pp. 1040-1041. https://doi.org/10.1016/j.jcin.2021.03.037

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Combined Chronic Kidney and Liver Disease
Elbadawi, A, Elzeneini, M, Thakker, R, Shnoda, M, Omer, M, Shahin, HI, Kapadia, SR, Kleiman, NS, Reardon, MJ & Goel, SS 2021, , JACC: Cardiovascular Interventions, vol. 14, no. 9, pp. 1047-1049. https://doi.org/10.1016/j.jcin.2021.03.009

Outcomes of Prosthesis-Patient Mismatch Following Supra-Annular Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry
Tang, GHL, Sengupta, A, Alexis, SL, Bapat, VN, Adams, DH, Sharma, SK, Kini, AS, Kodali, SK, Ramlawi, B, Gada, H, Vora, AN, Forrest, JK, Kaple, RK, Liu, F & Reardon, MJ 2021, , JACC: Cardiovascular Interventions, vol. 14, no. 9, pp. 964-976. https://doi.org/10.1016/j.jcin.2021.03.040

Transcatheter Aortic Valve Implant Depth Measurements Differ by Aortography Versus Computed Tomography
Vora, AN, Tang, GHL, Reardon, MJ, Deeb, GM, Yakubov, SJ, Huang, J, Spencer, J & Gada, H 2021, , JACC: Cardiovascular Interventions, vol. 14, no. 9, pp. 1045-1047. https://doi.org/10.1016/j.jcin.2020.12.035

Tip-to-Base LAMPOON for Transcatheter Mitral Valve Replacement With a Protected Mitral Annulus
Lisko, JC, Babaliaros, VC, Khan, JM, Kamioka, N, Gleason, PT, Paone, G, Byku, I, Tiwana, J, McCabe, JM, Cherukuri, K, Khalil, R, Lasorda, D, Goel, SS, Kleiman, NS, Reardon, MJ, Daniels, DV, Spies, C, Mahoney, P, Case, BC, Whisenant, BK, Yadav, PK, Condado, JF, Koch, R, Grubb, KJ, Bruce, CG, Rogers, T, Lederman, RJ & Greenbaum, AB 2021, , JACC: Cardiovascular Interventions, vol. 14, no. 5, pp. 541-550. https://doi.org/10.1016/j.jcin.2020.11.034

Evaluating Out-of-Hospital 30-Day Mortality After Transfemoral Transcatheter Aortic Valve Replacement: An STS/ACC TVT Analysis
Anwaruddin, S, Desai, ND, Vemulapalli, S, Marquis-Gravel, G, Li, Z, Kosinski, A & Reardon, MJ 2021, , JACC: Cardiovascular Interventions, vol. 14, no. 3, pp. 261-274. https://doi.org/10.1016/j.jcin.2020.10.027

CT—Guided Endovascular Exclusion of Pseudoaneurysmal Subclavian Bypass After Early-Age Surgical Correction of Complex Aortic Coarctation
El Nihum, LI, Li, Z, Chinnadurai, P, Bavare, CS, Reardon, MJ, MacGillivray, TE & Lin, CH 2021, , JACC: Case Reports, vol. 3, no. 2, pp. 225-229. https://doi.org/10.1016/j.jaccas.2020.11.026

Commentary: Primary cardiac sarcoma—Systemic disease requires systemic therapy
Ravi, V & Reardon, MJ 2021, , Journal of Thoracic and Cardiovascular Surgery, vol. 161, no. 1, pp. 120-121. https://doi.org/10.1016/j.jtcvs.2019.10.087

Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart Failure
Tayal, B, Debs, D, Nabi, F, Malahfji, M, Little, SH, Reardon, M, Zoghbi, W, Kleiman, N & Shah, DJ 2021, , JACC: Cardiovascular Imaging, vol. 14, no. 4, pp. 812-822. https://doi.org/10.1016/j.jcmg.2020.11.004

The International Society for Minimally Invasive Cardiothoracic Surgery Expert Consensus Statement on Transcatheter and Surgical Aortic Valve Replacement in Low- and Intermediate-Risk Patients: A Meta-Analysis of Randomized and Propensity-Matched Studies
Thourani, VH, Edelman, JJ, Holmes, SD, Nguyen, TC, Carroll, J, Mack, MJ, Kapadia, S, Tang, GHL, Kodali, S, Kaneko, T, Meduri, CU, Forcillo, J, Ferdinand, FD, Fontana, G, Suwalski, P, Kiaii, B, Balkhy, H, Kempfert, J, Cheung, A, Borger, MA, Reardon, M, Leon, MB, Popma, JJ & Ad, N 2021, , Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, vol. 16, no. 1, pp. 3-16. https://doi.org/10.1177/1556984520978316

Reply: Boomer or barometer?
Reardon, MJ 2021, , Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2020.12.132

Relation of Institutional Mitral Valve Surgical Volume to Surgical and Transcatheter Outcomes in Medicare Patients
Barker, CM, Reynolds, MR, Reardon, MJ, Van Houten, JL, Murphy, SME, Mollenkopf, SA & Feldman, TE 2021, , American Journal of Cardiology, vol. 147, pp. 94-100. https://doi.org/10.1016/j.amjcard.2021.01.044

Commentary: Is there strength in frailty testing?
MacGillivray, TE & Reardon, MJ 2021, , Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2021.03.020

Commentary: There is strength in heart teams, whether or not the numbers add up
Wyler von Ballmoos, MC & Reardon, MJ 2021, , Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2021.03.029

Surgical Treatment of Benign Cardiac Tumors
MacGillivray, TE & Reardon, MJ 2021, , Operative Techniques in Thoracic and Cardiovascular Surgery. https://doi.org/10.1053/j.optechstcvs.2020.12.006

Surgical Treatment of Cardiac and Pulmonary Sarcomas
MacGillivray, TE & Reardon, MJ 2021, , Operative Techniques in Thoracic and Cardiovascular Surgery. https://doi.org/10.1053/j.optechstcvs.2020.12.005

Commentary: There's more than one way to skin a cat (thoraco)
Atkins, MD & Reardon, MJ 2021, , JTCVS Techniques, vol. 7, pp. 34-35. https://doi.org/10.1016/j.xjtc.2021.03.025